trial · primary record
5% Imiquimod cream
Basal Cell Carcinoma
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 1630 |
| Primary completion | 2032-10-06 |
| Primary endpoint | Proportion of participants with a new Basal Cell Carcinoma (BCC) on the face at 1 year |
| Registry ID | NCT05212246 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:19.572Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05212246
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.